Valve repair or replacement outcomes depend on initial hospital mortality, hemodynamic function, adverse device effects, and the postoperative progression of cardiac structural abnormalities.
Absolute Event Rate: 0% vs 0%
THE value to the patient of valve repair or replacement is determined by the resulting improvement in length and quality of life over that imposed by the natural history of the disease. The length and quality of life are determined by the initial hospital mortality rate, the hemodynamic function of the repaired valve or substituting device, adverse effects of the repaired valve or device (thromboembolism, infection, hemolysis, need for special therapy such as anticoagulants, or mechanical interference with cardiac performance), and the regression, persistence, or progression after operation of the abnormalities of cardiac structure and function that resulted originally from . . .
Kirklin et al. (Thu,) reported a other. Valve repair or replacement outcomes depend on initial hospital mortality, hemodynamic function, adverse device effects, and the postoperative progression of cardiac structural abnormalities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: